A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study. (Q54645672)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

A phase 2 trial of imatinib mesylate in patients with recurrent nonresectable chondrosarcomas expressing platelet-derived growth factor receptor-α or -β: An Italian Sarcoma Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

phase II clinical trial

0 references

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Emanuela Palmerini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Paolo Giovanni Casali

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Giovanni Grignani

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Silvia Stacchiotti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Virginia Ferraresi

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Massimo Aglietta

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Antonella Boglione

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Sergio Frustaci

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Alessandro Comandone

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Stefano Ferrari

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

language of work or name

0 references

publication date

5 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

117

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

826-831

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20925044%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

The clinical approach towards chondrosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Phase II study of high-dose photon/proton radiotherapy in the management of spine sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Carbon ion radiotherapy of skull base chondrosarcomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

PDGFRalpha, PDGFRbeta and KIT expression/activation in conventional chondrosarcoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Imatinib mesylate in chordoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

A validation study of an Italian version of the Brief Pain Inventory (Breve Questionario per la Valutazione del Dolore).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Dedifferentiated chondrosarcomas arising in preexisting osteochondromas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Complete response to imatinib in relapsing pigmented villonodular synovitis/tenosynovial giant cell tumor (PVNS/TGCT).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Heterogeneity of kinase inhibitor resistance mechanisms in GIST

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Genomic profiling of chondrosarcoma: chromosomal patterns in central and peripheral tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Imatinib plus low-dose doxorubicin in patients with advanced gastrointestinal stromal tumors refractory to high-dose imatinib: a phase I-II study by the Spanish Group for Research on Sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

COX-2 expression in chondrosarcoma: a role for celecoxib treatment?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

21 January 2018

Platelet-derived growth factor-alpha receptor expression supports the growth of conventional chondrosarcoma and is associated with adverse outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

7 January 2021

based on heuristic

inferred from DOI database lookup

Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

7 January 2021

based on heuristic

inferred from DOI database lookup

Array CGH analysis in primary gastrointestinal stromal tumors: Cytogenetic profile correlates with anatomic site and tumor aggressiveness, irrespective of mutational status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

7 January 2021

based on heuristic

inferred from DOI database lookup

Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25632

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54645672&oldid=2043604785"